US Patent Issued to Immatics Biotechnologies on April 15 for "Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers" (German Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,776, issued on April 15, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers" was invented by Andrea Mahr (Tuebingen, Germany), Toni Weinschenk (Tuebingen, Germany), Anita Wiebe (Tuebingen, Germany), Colette Song (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany) and Harpreet Singh (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the pres...